Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-10-08Clinical Trial Update: Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer [NA]
A clinical trial evaluating celecoxib for pain, weight loss, and weakness in advanced cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-11Clinical Trial Update: Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating intramuscular electrotransfer of plasmid AMEP in patients with advanced or metastatic melanoma has bee…
-
CLINICAL_TRIALS withdrawal · 2015-07-23Clinical Trial Update: Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma [NA]
A clinical trial evaluating isolated limb perfusion with melphalan for stage IIIB-IV melanoma or soft tissue sarcoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-15Clinical Trial Update: Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma [Phase 2]
A Phase 2 trial evaluating the combination of sorafenib and temsirolimus for metastatic, recurrent, or unresectable melanoma has been withdr…
-
CLINICAL_TRIALS withdrawal · 2015-03-13Clinical Trial Update: A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma [Phase 1]
The Phase I trial of normothermic isolated limb infusion with melphalan plus buthionine sulfoximine (BSO) for locally advanced malignant mel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-12-23Clinical Trial Update: Autonomic Phenotype Before and After Akt Inhibition
This clinical trial update notes that the study evaluating autonomic phenotype changes before and after Akt inhibition in melanoma patients …
-
CLINICAL_TRIALS withdrawal · 2014-07-18Clinical Trial Update: Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma [Phase 1, Phase 2]
The clinical trial investigating isolated limb infusion chemotherapy with targeted gene therapy for advanced, unresectable extremity melanom…
-
CLINICAL_TRIALS withdrawal · 2014-04-01Clinical Trial Update: Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of an anti-OX40 antibody with ipilimumab in metastatic melanoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-02-04Clinical Trial Update: Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating CC-486 with Nab-Paclitaxel vs Nab-Paclitaxel in chemotherapy-naïve metastatic melanoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-05-15Clinical Trial Update: Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma [Phase 2]
A Phase 2 trial evaluating ipilimumab with or without vaccine therapy for previously treated stage IV melanoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-05-13Clinical Trial Update: High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma [Phase 3]
The Phase 3 trial evaluating high-dose interferon alfa for stage II or stage III melanoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-05Clinical Trial Update: Open-Label Study of TPI 287 for Patients With Metastatic Melanoma [Phase 1, Phase 2]
The open-label Phase 1/2 trial of TPI-287 for metastatic melanoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-07Clinical Trial Update: Study of Immune Responses in Patients With Metastatic Melanoma [Phase 2]
A Phase 2 study evaluating immune responses in patients with metastatic melanoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-01-31Clinical Trial Update: RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery [Phase 2]
The Phase 2 clinical trial of RO4929097 for surgically removable Stage IIIB/IIIC/Stage IV melanoma sponsored by the NCI has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-12Clinical Trial Update: Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]
A Phase 2 trial investigating interleukin-2 with sargramostim after chemotherapy for stage III/IV melanoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-02-22Clinical Trial Update: Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients [NA]
A pilot study evaluating interstitial fluid pressure in melanoma patients has been withdrawn from the registry.
-
CLINICAL_TRIALS withdrawal · 2012-01-26Clinical Trial Update: IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma [Phase 1, Phase 2]
The Phase 1/2 trial of IPI-Biotherapy for metastatic melanoma in patients previously treated with cytotoxic chemotherapy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-12-13Clinical Trial Update: Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma [Phase 1]
Phase 1 biomarker study of an anti-PD-L1 agent for advanced melanoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-11-21Clinical Trial Update: Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma [Phase 1]
A Phase 1 trial evaluating the combination of an anti-CD137 antibody with ipilimumab in melanoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-11-02Clinical Trial Update: Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.
A clinical trial (NCT00184288) evaluating proton MR spectroscopy for evaluating treatment response in brain metastases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2009-12-14Clinical Trial Update: Treatment Use Study for Advanced Melanoma.
The Pfizer-sponsored treatment use study for advanced unresectable melanoma is no longer available.
-
EMA withdrawal · 2009-03-16EMA Application withdrawn: Cylatron (peginterferon alfa-2b) — SP Europe
European Medicines Agency report indicates withdrawal of the application for Cylatron (peginterferon alfa-2b) for melanoma by SP Europe.